Accelerating antibody discovery with cell-free DNA synthesis

Advances in synthetic biology and automation accelerate high throughput antibody screening.

Developing antibody therapeutics requires multiple arduous steps, including synthesizing lead candidate genes, cloning them into vectors, and amplifying plasmids in Escherichia coli cells. Recent strides in synthetic biology and automation have enabled the efficient in vitro generation of synthetic DNA products. In this webinar brought to you by Telesis Bio, Jasmine Hershewe will discuss a cell-free approach to automating DNA printing, cloning, and amplification, expediting the screening and identification of lead antibody candidates. 

Topics to be covered

  • Generating DNA constructs for small-scale antibody expression and screening
  • Transitioning from digital sequences to transfection ready DNA within a week

Wednesday, December 6th, 2023 | 11:00 AM - 12:00 PM Eastern Time
This webinar will be available to view live and on demand.


Jasmine Hershewe, PhD

Jasmine Hershewe, PhD

Field Application Scientist, Manager
Telesis Bio

Sponsored by